JR

Jyotsnaben Rajeshkumar Joshi

Active Director Director DIN 10994404
DIN 10994404 First appointment Mar 2025 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Jyotsnaben Rajeshkumar Joshi

Data last updated:

Jyotsnaben Rajeshkumar Joshi is a Director at Woodsnow Pharmaceuticals Private Limited (since 2025). The company operates in Paper.

DIN 10994404
Primary Designation Director
Industry Paper
First Appointment 10 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Mar 20252025Active

Board colleagues of Jyotsnaben Rajeshkumar Joshi

Directorship timeline

Open interactive timeline →
Woodsnow Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jyotsnaben Rajeshkumar Joshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jyotsnaben Rajeshkumar Joshi

Jyotsnaben Rajeshkumar Joshi currently holds 1 directorship: Woodsnow Pharmaceuticals Private Limited (Director, since 10 Mar 2025).

Jyotsnaben Rajeshkumar Joshi was first appointed on 10 Mar 2025 as Director at Woodsnow Pharmaceuticals Private Limited.

The current boards of Jyotsnaben Rajeshkumar Joshi's companies include Bhavnaben Jitendrabhai Patel (Woodsnow Pharmaceuticals Private Limited), Jagruti Bharat Doshi (Woodsnow Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available